论文部分内容阅读
呼吸道病毒是儿童呼吸系统疾病的重要病原。病毒感染全年龄段均可发病，以年幼儿童为高发人群。大多数病毒感染预后良好，特殊病毒仍对患儿健康造成较大危害。呼吸道病毒治疗包括对症治疗、广谱抗病毒药、直接针对病毒复制周期的药物、减弱炎症反应药物、抗病毒纳米药物等。新的抗病毒药物开发迫在眉睫。探索临床已知药物的新用途也是有效的方法。呼吸道病毒感染的治疗已成为临床研究的重要课题。“,”Respiratory virus remains to be an important pathogen of respiratory disease in children.The disease can occur in all age groups, especially in young children.Most viral infections have a good prognosis, but special viruses still cause great harm to the health of children.Respiratory viral therapy includes symptomatic therapy, broad-spectrum antiviral drugs, drugs that directly target the viral replication cycle, drugs that attenuate the inflammatory response, and anti-viral nanodrugs.New antiviral drugs are urgently needed to develop.The repurposing of the existing therapeutic agents previously designed for other virus infections is also an effective way.The treatment of respiratory virus infection has become an important topic in clinical research.